| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HSS0
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
| GO:0006401 | RNA catabolic process | 5 | 1 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
| GO:0008152 | metabolic process | 1 | 1 |
| GO:0009056 | catabolic process | 2 | 1 |
| GO:0009057 | macromolecule catabolic process | 4 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0016070 | RNA metabolic process | 5 | 1 |
| GO:0019439 | aromatic compound catabolic process | 4 | 1 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
| GO:0034655 | nucleobase-containing compound catabolic process | 4 | 1 |
| GO:0043137 | DNA replication, removal of RNA primer | 6 | 1 |
| GO:0043170 | macromolecule metabolic process | 3 | 1 |
| GO:0044237 | cellular metabolic process | 2 | 1 |
| GO:0044238 | primary metabolic process | 2 | 1 |
| GO:0044248 | cellular catabolic process | 3 | 1 |
| GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
| GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
| GO:0044270 | cellular nitrogen compound catabolic process | 4 | 1 |
| GO:0046483 | heterocycle metabolic process | 3 | 1 |
| GO:0046700 | heterocycle catabolic process | 4 | 1 |
| GO:0071704 | organic substance metabolic process | 2 | 1 |
| GO:0090304 | nucleic acid metabolic process | 4 | 1 |
| GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
| GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
| GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 7 | 1 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
| GO:1901361 | organic cyclic compound catabolic process | 4 | 1 |
| GO:1901575 | organic substance catabolic process | 3 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000287 | magnesium ion binding | 5 | 12 |
| GO:0003676 | nucleic acid binding | 3 | 12 |
| GO:0003824 | catalytic activity | 1 | 12 |
| GO:0004518 | nuclease activity | 4 | 12 |
| GO:0004519 | endonuclease activity | 5 | 12 |
| GO:0004521 | RNA endonuclease activity | 5 | 12 |
| GO:0004523 | RNA-DNA hybrid ribonuclease activity | 7 | 12 |
| GO:0004540 | RNA nuclease activity | 4 | 12 |
| GO:0005488 | binding | 1 | 12 |
| GO:0016787 | hydrolase activity | 2 | 12 |
| GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
| GO:0016891 | RNA endonuclease activity, producing 5'-phosphomonoesters | 6 | 12 |
| GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 12 |
| GO:0043167 | ion binding | 2 | 12 |
| GO:0043169 | cation binding | 3 | 12 |
| GO:0046872 | metal ion binding | 4 | 12 |
| GO:0097159 | organic cyclic compound binding | 2 | 12 |
| GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
| GO:1901363 | heterocyclic compound binding | 2 | 12 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 235 | 239 | PF00656 | 0.404 |
| CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.433 |
| CLV_Separin_Metazoa | 203 | 207 | PF03568 | 0.435 |
| DEG_SPOP_SBC_1 | 19 | 23 | PF00917 | 0.680 |
| DOC_ANK_TNKS_1 | 188 | 195 | PF00023 | 0.433 |
| DOC_CYCLIN_yCln2_LP_2 | 118 | 124 | PF00134 | 0.349 |
| DOC_CYCLIN_yCln2_LP_2 | 201 | 207 | PF00134 | 0.446 |
| DOC_MAPK_MEF2A_6 | 120 | 127 | PF00069 | 0.300 |
| DOC_PP4_FxxP_1 | 64 | 67 | PF00568 | 0.218 |
| DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.633 |
| DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.587 |
| DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.632 |
| LIG_14-3-3_CanoR_1 | 173 | 178 | PF00244 | 0.432 |
| LIG_14-3-3_CanoR_1 | 206 | 213 | PF00244 | 0.435 |
| LIG_14-3-3_CanoR_1 | 62 | 67 | PF00244 | 0.296 |
| LIG_14-3-3_CterR_2 | 246 | 250 | PF00244 | 0.465 |
| LIG_APCC_ABBA_1 | 125 | 130 | PF00400 | 0.238 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.542 |
| LIG_FHA_1 | 103 | 109 | PF00498 | 0.300 |
| LIG_FHA_1 | 117 | 123 | PF00498 | 0.381 |
| LIG_FHA_2 | 210 | 216 | PF00498 | 0.472 |
| LIG_KLC1_Yacidic_2 | 31 | 36 | PF13176 | 0.313 |
| LIG_LIR_Gen_1 | 172 | 179 | PF02991 | 0.504 |
| LIG_LIR_Nem_3 | 111 | 116 | PF02991 | 0.237 |
| LIG_LIR_Nem_3 | 162 | 167 | PF02991 | 0.247 |
| LIG_LIR_Nem_3 | 172 | 177 | PF02991 | 0.300 |
| LIG_SH2_CRK | 174 | 178 | PF00017 | 0.456 |
| LIG_SH2_SRC | 34 | 37 | PF00017 | 0.273 |
| LIG_SH2_STAP1 | 141 | 145 | PF00017 | 0.365 |
| LIG_SH2_STAT3 | 178 | 181 | PF00017 | 0.468 |
| LIG_SH2_STAT3 | 207 | 210 | PF00017 | 0.393 |
| LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.296 |
| LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.190 |
| LIG_SH2_STAT5 | 207 | 210 | PF00017 | 0.393 |
| LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.286 |
| LIG_SUMO_SIM_anti_2 | 217 | 224 | PF11976 | 0.382 |
| LIG_SUMO_SIM_anti_2 | 238 | 245 | PF11976 | 0.404 |
| LIG_TRAF2_2 | 157 | 162 | PF00917 | 0.300 |
| MOD_CK1_1 | 6 | 12 | PF00069 | 0.645 |
| MOD_CK2_1 | 150 | 156 | PF00069 | 0.365 |
| MOD_GlcNHglycan | 109 | 113 | PF01048 | 0.300 |
| MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.641 |
| MOD_GSK3_1 | 17 | 24 | PF00069 | 0.661 |
| MOD_GSK3_1 | 205 | 212 | PF00069 | 0.591 |
| MOD_GSK3_1 | 37 | 44 | PF00069 | 0.333 |
| MOD_GSK3_1 | 6 | 13 | PF00069 | 0.697 |
| MOD_GSK3_1 | 68 | 75 | PF00069 | 0.383 |
| MOD_LATS_1 | 224 | 230 | PF00433 | 0.435 |
| MOD_N-GLC_1 | 116 | 121 | PF02516 | 0.223 |
| MOD_N-GLC_1 | 41 | 46 | PF02516 | 0.326 |
| MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.351 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.642 |
| MOD_NEK2_1 | 102 | 107 | PF00069 | 0.383 |
| MOD_NEK2_1 | 150 | 155 | PF00069 | 0.296 |
| MOD_NEK2_1 | 18 | 23 | PF00069 | 0.640 |
| MOD_NEK2_1 | 236 | 241 | PF00069 | 0.361 |
| MOD_NEK2_1 | 70 | 75 | PF00069 | 0.300 |
| MOD_PIKK_1 | 70 | 76 | PF00454 | 0.300 |
| MOD_PKA_2 | 205 | 211 | PF00069 | 0.580 |
| MOD_PKB_1 | 171 | 179 | PF00069 | 0.442 |
| MOD_Plk_1 | 102 | 108 | PF00069 | 0.230 |
| MOD_Plk_4 | 173 | 179 | PF00069 | 0.448 |
| MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.571 |
| MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.634 |
| TRG_DiLeu_BaEn_1 | 103 | 108 | PF01217 | 0.307 |
| TRG_DiLeu_BaEn_1 | 218 | 223 | PF01217 | 0.372 |
| TRG_ENDOCYTIC_2 | 174 | 177 | PF00928 | 0.398 |
| TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.396 |
| TRG_ER_diArg_1 | 168 | 171 | PF00400 | 0.326 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PC83 | Leptomonas seymouri | 61% | 72% |
| A0A0S4IX23 | Bodo saltans | 38% | 82% |
| A0A1X0NJL6 | Trypanosomatidae | 32% | 69% |
| A0A3R7MD61 | Trypanosoma rangeli | 39% | 68% |
| A0A3S7WPF2 | Leishmania donovani | 99% | 100% |
| A4H4J5 | Leishmania braziliensis | 83% | 100% |
| C9ZTC3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 83% |
| E9AKQ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
| O60930 | Homo sapiens | 28% | 87% |
| O70338 | Mus musculus | 27% | 88% |
| Q4QJ50 | Leishmania major | 96% | 100% |
| Q5BK46 | Rattus norvegicus | 27% | 88% |
| Q9UST8 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 29% | 95% |
| V5BEV1 | Trypanosoma cruzi | 38% | 77% |